Tranexamic acid autoinjector for prehospital care of noncompressible hemorrhage

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 5 SUPPL.1, 2011, Pages

  Culligan, W Brent ^a   Tien, Homer C ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

ARTICLE; BLEEDING; CANADA; EMERGENCY CARE; HEMOSTASIS; HUMAN; INJECTION PISTOL; MILITARY MEDICINE; NONCOMPRESSIBLE HEMORHAGE; NONCOMPRESSIBLE HEMORRHAGE; OCCUPATIONAL HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TACTICAL COMBAT CASUALTY CARE; TRAUMATOLOGY;

ANTIFIBRINOLYTIC AGENTS; AUTOMATION; EMERGENCY MEDICAL SERVICES; EQUIPMENT DESIGN; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; INJECTIONS; TRANEXAMIC ACID;

EID: 81455141694     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318232ea1e     Document Type: Article

References (19)

1. Butler FK, Jr., Hagmann J, Butler EG. Tactical combat casualty care in special operations. Mil Med. 1996;161(suppl):3-16. (Pubitemid 26271379)
2. Butler FK Jr. Tactical combat casualty care: combining good medicine with good tactics. J Trauma. 2003;54(suppl):S2-S3.
3. Blumenfeld A, Kluger Y, Ben Abraham R, Stein M, Rivkind A. Combat trauma life support training versus the original advanced trauma life support course: the impact of enhanced curriculum on final student scores. Mil Med. 1997;162:463-467. (Pubitemid 27412827)
4. Hawley A. Trauma management on the battlefield: a modern approach. J R Army Med Corps. 1996;142:120-125.
5. King RB, Filips D, Blitz S, Logsetty S. Evaluation of possible tourniquet systems for use in the Canadian Forces. J Trauma. 2006;60:1061-1071. (Pubitemid 43778644)
6. Bellamy RF. The causes of death in conventional land warfare: implications for combat casualty care research. Mil Med. 1984;149:55-62.
7. Kelly JF, Ritenour AE, McLaughlin DF, et al. Injury Severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma. 2007;64:S21-S26; discussion S26-S27.
8. CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23-32.
9. The CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377:1096-1101.
10. Peng R, Chang C, Gilmore D, Bongard F. Epidemiology of immediate and early trauma deaths at an urban Level I trauma center. Am Surg. 1998;64:950-954. (Pubitemid 28462660)
11. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001;4:CD001886.
12. Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res. 2009;1214:608-613.
13. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69:489-500.
14. Bulger EM, May S, Brasel KJ, et al; ROC Investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010;304:1455-1464.
15. Benoni G, Bjorkman S, Fredin H. Application of pharmacokinetics data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest. 1995;10:280-287.
16. Sano M, Hakusui H, Kojima C, Akimoto T. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers. Jpn J Clin Pharmacol Therapeutics. 1976;7:375-382.
17. Puigdellivol E, Carral ME, Moreno J, Pla-Delfina JM, Jané F. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man. Int J Clin Pharmacol Ther Toxicol. 1985;23:298-301. (Pubitemid 15058879)
18. Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20:65-72. (Pubitemid 11072744)
19. Wetherell J, Price M, Mumford H, Armstrong S, Scott L. Development of next generation medical countermeasures to nerve agent poisoning. Toxicology. 2007;233:120-127. (Pubitemid 46509685)